fda warning letters glp-1 compounders october 2025 Troubling Findings in Study of Last month, the FDA issued

Digestive Disease and Sciences

Obesity comes with many risks, including higher risks for diabetes, high cholesterol, heart attack, stroke, heart disease, liver disease, high blood pressure and certain cancers

However, as clinicians celebrate these advances, a Read More Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes May 19, 2026 Articles, Blood Glucose Control, Devices, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Metformin Therapy Center, SGLT-2 Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,725 views Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults

My final thoughts (& where you can get support) The bottom line